You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仟源醫藥(300254.SZ):子公司獲得”富馬酸盧帕他定衍生物、其製備方法及中間體和用途“發明專利
格隆匯 11-10 16:28

格隆匯 11 月 10日丨仟源醫藥(300254.SZ)公佈,公司之子公司杭州仟源保靈藥業有限公司於近日收到國家知識產權局頒發的“富馬酸盧帕他定衍生物、其製備方法及中間體和用途”發明專利證書。

富馬酸盧帕他定衍生物、其製備方法及中間體和用途,是應用於抗過敏藥富馬酸盧帕他定原料藥及製劑衍生物的製備及結構鑑定。通過對富馬酸盧帕他定衍生物LP?3的製備及結構鑑定,能夠為富馬酸盧帕他定原料藥及製劑的定性和定量分析提供品質優異、純度較高的對照品,從而對富馬酸盧帕他定原料藥及製劑的製備及其應用具有良好的指導意義,該方法可用於富馬酸盧帕他定原料藥及製劑的質量控制。富馬酸盧帕他定原料藥及其製劑正在研發中,新專利的取得不會對公司生產經營產生重大影響,但有利於公司進一步完善知識產權保護體系,對提升公司的核心競爭力有着積極的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account